SLC38A3 Promotes the Proliferation and Migration of Tumor Cells and Predicts Poor Prognosis in Colorectal Cancer

Siyi Zhang1, Lingli Huang2, Youjie Zeng3

  • 1Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.

ACS Omega
|May 20, 2024
PubMed
Summary

This study identifies SLC38A3 as a key transporter gene in colorectal cancer (CRC). Upregulation of SLC38A3 promotes tumor cell proliferation and migration, suggesting it as a potential therapeutic target for CRC.